Companies
- Companies
- Company details
Vernalis plc
Out-licensing
Phase II Clinical Development of V10153 for the Treatment of Stroke More
Striking Weight Loss Observed in Phase I Study with V24343 in Overweight and Mildly Obese Volunteers
Striking Weight Loss Observed in Phase I Study with V24343 in Overweight and Mildly Obese Volunteers More
Related Reports
Market Research Reports provided by reports.iptechex.com
Mar 2011 - 68 pages - $500
Jun 2008 - 51 pages - $495
Nov 2010 - 329 pages - $600
Sep 2011 - 66 pages - $500
Feb 2011 - 33 pages - $125
May 2011 - 39 pages - $125
Jul 2010 - 132 pages - $750
Jan 2010 - 275 pages - $1,125
Nov 2010 - 146 pages - $600
Sep 2010 - 12 pages - $99
Contact details
N Scott
Business Development
Head office
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us